Singapore Paincare Holdings Limited
Our Group is one of few medical services groups in Singapore focused on providing pain care treatments, through our advances in stopping pain, via specialized injections and minimally invasive procedures. All the doctors are trained and certified to be able to perform the procedures with great proficiency and accuracy, thereby giving long lasting excellent outcomes for our patients.
See below for the Latest Singapore Paincare Holdings Limited News, Analysis, Profit Results, Share Price Information, and Commentary.
Singapore Paincare sinks to net loss on rising staff expenses
Singapore Paincare sinks to net loss on rising staff expenses
The group posted a $47,000 net loss in HY2026, reversing last year’s $781,000 profit.
Singapore Paincare reports $3.74m net loss in FY2025
Company revenue drops 3.5% to $25.97m in FY2025.
Singapore Paincare dispute settled
The company returned $450,000 security under agreed terms.
Singapore Paincare Holdings expects loss for FY2025
In unaudited accounts, the firm cited losses from revenue decline and increased expenses.
Singapore Paincare invests $1.5m in digital transformation
UCrest will help the company in its digitisation.
SBR National Business Awards 2023 Winner: Singapore Paincare Holdings Limited
Singapore Pain Care Holdings Limited clinches the win at the SBR National Business Awards 2023 for its revolutionary DR+ Medical & Paincare initiative.
Singapore Paincare Holdings win to award for the primary care clinic brand
It was awarded in the healthcare category of the SBR National Business Awards.
Read Here
Advertise
Sign Up
Commentary
Singapore’s tourism economy depends on security infrastructure most never see
Where does value creation really happen?
Managing the cost of diverging standards: Why Singapore matters
Singapore’s AI ambition has an intelligence problem
Singapore is deploying AI at speed – and security risks are catching up
Precious metal boom is a stress test for Singapore’s gold ambitions
Singapore’s global dispute fault lines
‘Tokenmaxxing’ – The wrong AI race to run in Singapore
To outsmart modern fraud, we must first know the enemy